Role of temporary stents in alternative treatment of benign prostatic hyperplasia

Journal of Endourology

Volumn 11, Issue 6, 1997, Pages 467-472

  De La Rosette, J J M C H ^a   Beerlage, H P ^a   Debruyne, F M J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

POLYGLYCOLIC ACID; POLYURETHAN;

CONFERENCE PAPER; ENDOUROLOGY; HEAT TREATMENT; HUMAN; MALE; MORBIDITY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; STENT; TRANSURETHRAL RESECTION; URINE RETENTION;

EID: 0031435754     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.1997.11.467     Document Type: Conference Paper

References (24)

1. Barry MJ: Epidemiology and natural history of benign prostatic hyperplasia. Urol Clin North Am 1990;17:495-507
2. Lepor H, Rigaud G: The efficacy of transurethral resection of the prostate in men with moderate symptoms of prostatism. J Urol 1990;143:533-537
3. de Wildt MJAM, de la Rosette JJMCH, Debruyne FMJ: Retreatment rate, in: Kurth K-H, Newling DWW (eds): Benign Prostatic Hyperplasia: Recent Progress in Clinical Research and Practice. New York: Wiley-Liss, 1994, pp 597-613
4. Christensen MM, Bruskewitz RC: Clinical manifestation of benign prostatic hyperplasia and indication for therapeutic intervention. Urol Clin North Am 1990;17:509-516
5. Mebust WK, Holtgrewe HL, Cockett ATK, Peters PC: Transurethral prostatectomy: immediate and postoperative complications: a cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989;141:243-247
6. Nielssen KK, Nordling J: Urethral strictures following transurethral prostatectomy. Urology 1990;35:18-24
7. Fowler FJ, Wemberg JE, Timothy RP, Barry MJ, Mulley AG, Hanley D: Symptom status and quality of life following prostatectomy. JAMA 1988;259:3018-3022
8. Jardin A, Bensadoun H, Delauchecavallier MC, et al: Long-term treatment of benign prostatic hyperplasia with alfuzosin: a 24-30 month survey. Br J Urol 1994;74:579-584
9. Lepor H: Long-term efficacy and safety of terazosin in patients with benign prostatic hyperplasia. Urology 1994;45:406
10. Stoner E: Three year safety and efficacy data on the use of finasteride in the treatment of benign prostatic hyperplasia. Urology 1994;43:284-294
11. Madesbacher S, Kratzik C, Susani M, Marberger M: Tissue ablation in benign prostatic hyperplasia with high intensity focused ultrasound. J Urol 1994;152:1956
12. Schulman CC, Zlotta AR: Transurethral needle ablation of the prostate: a new treatment of benign prostatic hyperplasia using interstitial low-level radiofrequency energy. Curr Opin Urol 1995; 5:35-40
13. te Slaa E, de la Rosette JJMCH: Lasers in the treatment of benign prostatic obstruction: past, present and future. Eur Urol 1996; 30:1-10
14. de la Rosette JJMCH, D'Ancona FCH, Debruyne FMJ: Current status of thermotherapy of the prostate. J Urol 1997;157:430-438
15. Edwards LE. History of non-surgical treatment. In: Hinman F Jr (ed): Benign Prostatic Hypertrophy. New York: Springer Verlag, 1983, p 30
16. Dotter CT: Transluminally-placed coilspring endoartenal tube grafts: long-term in canine popliteal artery. Invest Radiol 1969; 4:329-332
17. Fabian KM: The intraprostatic "partial catheter" (urological spiral). Urologe [A] 1980;19:236-238
18. Kemppainen E, Talja M, Riihela M, Pohjonen T, Tormala P, Alfthan O: A bioresorbable stent: an experimental study. Urol Res 1993;21:235-238
19. Nissenkomi, Slutzker D, Shalev M: Use of an intraurethral catheter instead of a Foley catheter after laser treatment of benign prostatic hyperplasia. Eur Urol 1996;29:341-344
20. Barnes DG, Butterworth P, Flynn JT: Combined endoscopie laser ablation of the prostate (ELAP) and temporary prostatic stenting. Min Invas Ther Allied Technol 1996;5:333-335
21. Talja M, Tammela T, Petas A, Vamaa T, Taari K, Viherkoski E, Törmälä P: Biodegradable self-reinforced polyglycolic acid spiral stent in prevention of postoperative urinary retention after visual laser ablation of the prostate-laser prostatectomy. J Urol 1995; 154:2089-2092
22. Pétas A, Talja M, Tammela T, Taari K, Lehtoranta, Välimaa T, Törmälä: A randomized study to compare biodegradable self-reinforced polyglycolic acid spiral stents to suprapubic and indwelling catheters after visual laser ablation of the prostate. J Urol 1997;157:173-176
23. Dahlstrand C, Grundtman S, Pettersson S: High energy TUMT for large severely obstructing BPH and the use of biodegradable stents to avoid posttreatment catheterization. Br J Urol (in press)
24. Devonec M: Self retaining intra-urethral catheter for prevention of post-operative urinary retention: experience after microwave therapy of the prostate. J Urol 1997 (submitted)